MedPath

Study of the Aerosol Deposition With Vented and Unvented Jet Nebulizer in Healthy Subjets

Not Applicable
Conditions
Aerosol Drug Therapy
Registration Number
NCT01428323
Lead Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Brief Summary

Open-vent jet nebulizers are frequently used to promote drug lung deposition but their clinical efficacy and indications are not clear.

Our study aimed to compare inhaled mass, and lung deposition of amikacin by using a jet nebulizer (Sidestream) under two different configurations: vented and unvented coupled to a 110 ml corrugated piece of tubing.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
7
Inclusion Criteria
  • Healthy Volunteers between 18 and 60 years old
Exclusion Criteria
  • Smokers
  • Pathological spirometry
  • History of treatment with aminoglygosides 1 month prior the study
  • Known allergy to aminoglycosydes
  • Any lung pathology or history of lung surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Amikacin Urinatory excretionEach miction during 24 hours
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Cliniques Universitaires Saint-Luc

🇧🇪

Bruxelles, Belgium

© Copyright 2025. All Rights Reserved by MedPath